Abstract
Recurrence of hepatitis C virus (HCV) after liver transplantation (LT) is a universal phenomenon. Recent reports have suggested an earlier and more aggressive recurrence in the living donor liver transplant (LDLT) population. The aim of this study was to compare the histological recurrence of HCV after LDLT versus deceased donor transplantation (DDT). Twenty-nine patients underwent LT for HCV-related end-stage liver disease at our institution between April 2001 and March 2003 (42 months). Twenty patients underwent DDT, and nine patients LDLT. Laboratory data were collected on a weekly to biweekly basis and HCV PCR was performed before LT and 3–4 months and yearly post-LT. Liver biopsies were performed as needed and per institutional protocol at 7 days, at 4 months, and yearly thereafter. All biopsies were evaluated by a single pathologist and scored for rejection (Banff score) and chronic hepatitis (Ishak score system). The predominant genotype in the DDT and LDLT groups was genotype 1 (DDT=70%, LDLT=79%). HCV RNA titers pre-LT and 3–4 months after LT did not differ. The incidence of rejection was higher in the DDT group (P < 0.05). There was a trend toward improved lshak stage and grade in the LDLT group at 4 and 12 months post-LT, however, this trend did not reach statistical significance. No histological difference in the recurrence or severity rate was observed at 4 or 12 months post-LT in the DDT group vs. the LDLT group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Wong JB, McQuillan GM, McHutchison JG, Poynard T: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 90:1562–1569, 2000
Davis GL AJ, Cook S, Rosenberg D: Projecting the future healthcare burden from hepatitis C in the United States. Hepatology 82:390A, 1998
Ghobrial RM, Steadman R, Gornbein J, et al.: A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 234:384–394, 2001
Prieto M, Berenguer M, Rayon JM, et al.: High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29:250–256, 1999
Berenguer M, Lopez-Labrador FX, Wright TL: Hepatitis C and liver transplantation. J Hepatol 35:666–678, 2001
Gane EJ, Portmann BC, Naoumov NV, et al.: Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820, 1996
Feray C, Caccamo L, Alexander GJ, et al.: European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) group. Gastroenterology 117:619–625, 1999
Berenguer M, Ferrell L, Watson J, et al.: HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32:673–684, 2000
Testa G, Crippin JS, Netto GJ, et al.: Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transplant 6:553–561, 2000
Sanchez-Fueyo A, Restrepo JC, Quinto L, et al.: Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 73:56–63, 2002
Feray C, Gigou M, Samuel D, et al.: The course of hepatitis C virus infection after liver transplantation. Hepatology 20:1137–1143, 1994
Berenguer M, Prieto M, Rayon JM, et al.: Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 32:852–858, 2000
UNOS: www.UNOS.org, accessed 2003
Wachs ME, Bak TE, Karrer FM, et al.: Adult living donor liver transplantation using a right hepatic lobe. Transplantation 66:1313–1316, 1998
Gaglio PJ MS, Russo M, Lapointe-Rudow D, Emond JC, Brown RS: Hepatitis C recurrence in recipients of grafts from living vs. cadaveric liver donors. Hepatology 36:265A, 2002
Taniguchi MWM, Bak T, Trotter J, Kugelmans M, Everson G, Kam I: Hepatitis C recurrence in living donor liver transplantation. Am J Transplant 2002 (in press)
Goldberg EGF, Pomfret E, Pomposelli S, Fabry S, Lewis WD, Jenkins RL: Graft and patient survival in patients with HCV undergoing living donor liver transplantation compared to cadaveric liver transplantation. Hepatology 36:179A, 2002
Ishak K, Baptista A, Bianchi L, et al.: Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699, 1995
UNOS: 2001 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1991-2000. United Network for Organ Sharing and Ann Arbor, MI, University Renal Research and Education Association, 2001
Shiffman MFR, Stravitz RT, Luketic VA, Sanyal A, Mills AS, Contos MJ, Cotterell A, Maluf D, Posner MP: Histologic analysis of recurrent hepatitis C virus infection following living donor and cadaveric liver transplantation. Am J Transplant S5:3A:203, 2003
Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P: Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors. Pediatr Transplant 6:301–307, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodriguez-Luna, H., Vargas, H.E., Sharma, P. et al. Hepatitis C Virus Recurrence in Living Donor Liver Transplant Recipients. Dig Dis Sci 49, 38–41 (2004). https://doi.org/10.1023/B:DDAS.0000011599.78222.9e
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000011599.78222.9e